Category Archives: Pharmaceuticals

Would You Trust A Doctor Who Got Kickbacks To Prescribe Your Drugs?

I’m thinking, “Maybe not.” Yet, this sort of unethical practice goes on all the time. According to physician/activist Roy Poses, MD, there were at least four significant settlements of such cases during the last half of 2014 alone. And, by January 9th of our new year, another high profile case has already been settled. Officially, it is known as U.S. ex rel. Fragoules v. Daiichi Sankyo, Inc., Civil Action No. 10-10420 (D. Mass.).

Continue reading

Antibiotic development is always important

No question that a new antibiotic may be very beneficial–we always are fighting new resistance problems.

Continue reading

Here we go–diabetes, type II, is overdiagnosed and over treated?

I do not deny that diabetes is a serious problem.

Continue reading

Review of Ebola research and treatment developments

Hemorrhagic fevers are bad boys–killers, so even if the recent outbreak never got here, research on what to do is important and may lead to other developments that are beneficial.

Continue reading

Let’s talk prescription speed

I know, that sounds a little inflammatory, but assume, for a moment, that a speed drug (equivalent to the most addictive and dangerous drugs used illicitly in the US of A), was being proposed to be prescribed for your hyperactive or “active” or irritating boy child, age 4, 6, 8 or 10.

Continue reading

Josh Bloom formerly a Pharma guy, discusses Pharma markets and economics.

Josh is not my brother or my friend even, but is a recent addition to the ACSH staff of commentators and he has a Pharma insight that I don’t have and don’t want to have. Read this for some reality testing.

Continue reading

ACE inhibitors win

I always liked ACE Inhibitors and shied away from Angiotensin Receptor Blockers because of cost.

Now I am rewarded for being parsimonious.

Continue reading